Agilent Life Sciences SS Tumor Map Assay Probe, DNA, 16
The Agilent SureSelectXT HS2 DNA Tumor Map Assay Probe, 16 reactions (part number 5191-6993), is designed for use with the SureSelectXT HS2 DNA System. This product enables highly sensitive and specific targeted sequencing of tumor DNA, supporting comprehensive genomic profiling in cancer research. The probe set is optimized for hybrid capture-based enrichment, allowing for the detection of low-frequency variants and providing robust performance with challenging samples, such as those derived from formalin-fixed, paraffin-embedded (FFPE) tissues. The kit is suitable for use in next-generation sequencing workflows and supports up to 16 reactions per kit.